Index | All studies (n = 10) | Studies with low prevalence (≤15%) of PALN metastasis (n = 5) | Studies with high prevalence (>15%) of PALN metastasis (n = 5) |
---|---|---|---|
Sensitivity | 0.34 (0.10–0.72) | 0.05 (0–0.55) | 0.73 (0.53–0.87) |
Specificity | 0.97 (0.93–0.99) | 0.99 (0.90–1.00) | 0.93 (0.86–0.97) |
Positive LR | 12.49 (4.64–33.62) | 9.15 (0.37–226.46) | 10.62 (4.90–23.05) |
Negative LR | 0.68 (0.40–1.15) | 0.95 (0.82–1.11) | 0.29 (0.15–0.55) |
Diagnostic odds ratio | 18.49 (4.72–72.43) | 9.60 (0.35–261.70) | 36.80 (11.03–122.76) |
Data in parentheses are 95% CIs.